Compare Corning Incorporated (GLW) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corning Incorporated vs Recursion Pharmaceuticals Inc — how do they compare? Corning Incorporated trades at $165.36 (market cap $137.12B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Corning Incorporated is far larger — about 75.8× Recursion Pharmaceuticals Inc's market cap, and Corning Incorporated pays a 0.7% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| GLW | RXRX | |
|---|---|---|
Market Cap | $137.12B | $1.81B |
Sector | Technology | Health |
52-Week High | $255.79 | $6.79 |
52-Week Low | $64.52 | $2.84 |
Enterprise Value | $144.00B | $1.33B |
Dividend Yield | 0.7% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corning Incorporated
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
